arrow
返回
G

Genia Long

analysis group

10H指数
42论文数
636被引数
收录论文 11
发表时间
Postapproval Innovation For Oncology Drugs And The Inflation Reduction Act
err2024-10-01
err1
PREAI
errGrabowski, Henry; Dimasi, Joseph A.; Long, Genia
err分享
err收藏
The Roles Of Patents And Research And Development Incentives In Biopharmaceutical Innovation
err2015-02-01
err58
PREAI
errGrabowski, Henry G.; DiMasi, Joseph A.; Long, Genia
err分享
err收藏
err分享
err收藏
Evolving Brand-Name And Generic Drug Competition May Warrant A Revision Of The Hatch-Waxman Act
err2011-11-01
err37
errOAAI
errGrabowski, Henry G.; Kyle, Margaret; Mortimer, Richard; Long, Genia; Kirson, Noam
err分享
err收藏
Data exclusivity for biologics (vol 10, pg 15, 2011)
err2011-06-01
err0
errOAAI
errGrabowski, Henry; Long, Genia; Mortimer, Richard
err分享
err收藏
Commercial Importation of Prescription Drugs in the United States: Short-Run Implications
err2011-04-01
err2
PREAI
errDanzon, Patricia M.; Johnson, Scott J.; Long, Genia; Furukawa, Michael F.
err分享
err收藏
Data exclusivity for biologics
err2010-12-31
err17
PREAI
errGrabowski, Henry; Long, Genia; Mortimer, Richard
err分享
err收藏
The value of antihypertensive drugs: A perspective on medical innovation
err2007-01-01
err102
PREAI
errCutler, David M.; Long, Genia; Berndt, Ernst R.; Royer, Jimmy; Fournier, Andree-Anne; Sasser, Alicia; Cremieux, Pierre
err分享
err收藏
The market for follow-on biologics: How will it evolve?
err2006-09-01
err61
errOAAI
errGrabowski, Henry; Cockburn, Iain; Long, Genia
err分享
err收藏